or
Bookmark and Share
Cosmetic composition for the treatment of the hair and scalp containing in combination a poly-beta-alanine and nicotinic acid or an ester thereof
   
Document Number
US Patent 4840790
Issued Date
June 20, 1989
Link
Map
Abstract
A cosmetic composition for the treatment of the hair and scalp comprises in a cosmetically acceptable vehicle a combination of a water soluble polyamide of the poly-beta-alanine type and a nicotinic derivative selected from nicotinic acid or an ester thereof. This composition is employed in a process for improving the regrowth of hair and for delaying or retarding the appearance of an oily aspect of the hair.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
12
Comments:
no comments yet
Owner
L'Oreal (Paris,FR)
[*] Notice:The portion of the term of this patent subsequent to April 5, 2005 has been disclaimed.
Published
June 20, 1989
Application Number
06/865,441
Filed
May 21, 1986
US Classification
424/70.8   424/70.17
Int'l Classification
A61K   8/67   (20060101)   A61K   8/72   (20060101)   A61K   8/88   (20060101)   A61K   8/30   (20060101)  
Assistant Examiner
Attorney/Law Firm
Priority Data
May 22, 1985 [FR] 85 07703
USPTO Field of Search
424/70   524/99  
Related Patents
5833998 - Topical compositions for regulating the oily/shiny appearance of skin - Owned by The Procter & Gamble Company (Cincinnati, OH)

Disclosed are topical compositions for regulating the oily and/or shiny appearance of skin. The compositions contain: (a) an active for regulating the oily and/or shiny appearance of skin, said active consisting essentially of one or more compounds selected from the group consisting of niacinamide, pyridoxine, panthenol, and pantothenic acid, in an amount that is safe and effective for regulating the oily and/or shiny appearance of the skin; and (b) a cosmetically acceptable carrier for said active. Also disclosed are methods of regulating the oily and/or shiny appearance of skin by topical application of such compositions.

5451407 - Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug - Owned by ALZA Corporation (Palo Alto, CA)

The present invention is directed to the transdermal administration of methyl nicotinate and an irritating or sensitizing drug. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in irritating/sensitizing drug- and methyl nicotinate-transmitting relation with the skin site. The matrix contains sufficient amounts of irritating/sensitizing drug and of methyl nicotinate, in combination, to continuously administer to the skin for a predetermined period of time the drug to provide an effective therapeutic result. The invention is also directed to a method for either 1) preventing or reducing the irritation caused by an irritating drug or 2) preventing or reducing sensitization from occurring, as well as reducing or eliminating pain and discomfort occurring during the elicitation phase after sensitization has already been induced.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us